Contract manufacturing is where it's at, at least through 2015. Global Industry Analysts projects a $41-billion market, thanks in part to the "huge number" of biotechs that lack production operations. The analysts expect demand for liquid dosage form services to rise six percent annually. Services for solid dosage forms are expected to be the largest segment. GIA release